Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 18 | 2022 | 3451 | 2.000 |
Why?
|
Insulin Infusion Systems | 7 | 2022 | 217 | 1.620 |
Why?
|
Probiotics | 3 | 2020 | 377 | 1.270 |
Why?
|
Decision Support Systems, Clinical | 5 | 2022 | 1162 | 1.050 |
Why?
|
User-Computer Interface | 4 | 2021 | 1402 | 1.010 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2018 | 296 | 1.000 |
Why?
|
Malpractice | 4 | 2015 | 556 | 0.970 |
Why?
|
Meningitis, Meningococcal | 2 | 2015 | 44 | 0.970 |
Why?
|
Meningococcal Vaccines | 2 | 2015 | 94 | 0.930 |
Why?
|
Electronic Health Records | 11 | 2022 | 4763 | 0.840 |
Why?
|
Infant Nutritional Physiological Phenomena | 2 | 2016 | 351 | 0.830 |
Why?
|
Blood Glucose Self-Monitoring | 5 | 2022 | 457 | 0.820 |
Why?
|
Insulin | 9 | 2022 | 6592 | 0.810 |
Why?
|
Cerebral Palsy | 2 | 2018 | 471 | 0.810 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2021 | 20 | 0.780 |
Why?
|
Microbiology | 2 | 2019 | 73 | 0.760 |
Why?
|
Flour | 1 | 2020 | 21 | 0.740 |
Why?
|
Micronutrients | 4 | 2019 | 380 | 0.710 |
Why?
|
Iron Metabolism Disorders | 1 | 2017 | 24 | 0.600 |
Why?
|
Data Display | 1 | 2018 | 174 | 0.600 |
Why?
|
Hypoglycemic Agents | 9 | 2022 | 3149 | 0.590 |
Why?
|
Parasites | 1 | 2020 | 162 | 0.590 |
Why?
|
Clinical Laboratory Information Systems | 1 | 2018 | 108 | 0.580 |
Why?
|
Thiazolidines | 2 | 2015 | 69 | 0.580 |
Why?
|
Fungi | 1 | 2020 | 338 | 0.580 |
Why?
|
Pyrrolidonecarboxylic Acid | 2 | 2015 | 65 | 0.570 |
Why?
|
Basal Metabolism | 1 | 2018 | 161 | 0.570 |
Why?
|
Leydig Cell Tumor | 1 | 2016 | 28 | 0.560 |
Why?
|
Congenital Abnormalities | 1 | 2021 | 704 | 0.540 |
Why?
|
Energy Intake | 3 | 2019 | 2128 | 0.530 |
Why?
|
Neisseria meningitidis, Serogroup B | 1 | 2015 | 6 | 0.530 |
Why?
|
Nutrition Assessment | 2 | 2017 | 725 | 0.520 |
Why?
|
Infant, Newborn, Diseases | 1 | 2021 | 592 | 0.520 |
Why?
|
Italy | 6 | 2020 | 840 | 0.510 |
Why?
|
Hospital Information Systems | 1 | 2018 | 396 | 0.510 |
Why?
|
Functional Food | 1 | 2015 | 20 | 0.510 |
Why?
|
Disabled Children | 1 | 2018 | 251 | 0.510 |
Why?
|
Fibroblast Growth Factors | 1 | 2021 | 867 | 0.510 |
Why?
|
Thioctic Acid | 1 | 2015 | 28 | 0.510 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 1 | 2015 | 62 | 0.500 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2016 | 159 | 0.490 |
Why?
|
Vicia faba | 1 | 2014 | 3 | 0.490 |
Why?
|
Favism | 1 | 2014 | 3 | 0.490 |
Why?
|
Nutritional Status | 4 | 2018 | 1606 | 0.480 |
Why?
|
Malnutrition | 2 | 2018 | 638 | 0.460 |
Why?
|
Child | 31 | 2022 | 79758 | 0.460 |
Why?
|
Compensation and Redress | 1 | 2014 | 66 | 0.460 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 2014 | 94 | 0.460 |
Why?
|
Insurance, Liability | 1 | 2014 | 101 | 0.450 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2013 | 37 | 0.450 |
Why?
|
Respiratory Tract Infections | 3 | 2022 | 1001 | 0.450 |
Why?
|
Infant | 18 | 2022 | 36030 | 0.450 |
Why?
|
Pneumococcal Vaccines | 2 | 2015 | 397 | 0.440 |
Why?
|
Retinal Vasculitis | 1 | 2013 | 46 | 0.440 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 710 | 0.440 |
Why?
|
Uveitis, Anterior | 1 | 2013 | 102 | 0.430 |
Why?
|
Child, Preschool | 18 | 2022 | 42034 | 0.430 |
Why?
|
Vaccines, Conjugate | 1 | 2015 | 328 | 0.430 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 275 | 0.430 |
Why?
|
Paroxetine | 1 | 2013 | 182 | 0.420 |
Why?
|
Intestines | 2 | 2020 | 1907 | 0.420 |
Why?
|
Herpesvirus 3, Human | 1 | 2013 | 159 | 0.420 |
Why?
|
Feeding Behavior | 2 | 2016 | 3185 | 0.420 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2013 | 50 | 0.410 |
Why?
|
Folliculitis | 1 | 2012 | 25 | 0.410 |
Why?
|
Medical Records Systems, Computerized | 2 | 2018 | 1191 | 0.410 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 785 | 0.400 |
Why?
|
Rotavirus Vaccines | 1 | 2012 | 63 | 0.390 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2011 | 94 | 0.390 |
Why?
|
Adjuvants, Immunologic | 2 | 2015 | 1041 | 0.390 |
Why?
|
Rotavirus Infections | 1 | 2012 | 86 | 0.380 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2012 | 85 | 0.380 |
Why?
|
Plagiocephaly, Nonsynostotic | 1 | 2011 | 30 | 0.380 |
Why?
|
Biological Products | 1 | 2020 | 914 | 0.370 |
Why?
|
Diet, Gluten-Free | 1 | 2013 | 280 | 0.370 |
Why?
|
Carbamates | 1 | 2012 | 192 | 0.370 |
Why?
|
Excipients | 1 | 2011 | 97 | 0.360 |
Why?
|
Nutritive Value | 1 | 2013 | 349 | 0.360 |
Why?
|
Diarrhea | 1 | 2017 | 1341 | 0.360 |
Why?
|
Ritonavir | 1 | 2012 | 328 | 0.360 |
Why?
|
Drug Eruptions | 1 | 2013 | 335 | 0.360 |
Why?
|
Testicular Neoplasms | 1 | 2016 | 800 | 0.350 |
Why?
|
Pneumococcal Infections | 1 | 2015 | 503 | 0.350 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 822 | 0.350 |
Why?
|
HIV Protease Inhibitors | 1 | 2012 | 432 | 0.350 |
Why?
|
Pediatrics | 3 | 2015 | 3587 | 0.340 |
Why?
|
Insurance Claim Review | 1 | 2014 | 737 | 0.340 |
Why?
|
Humans | 83 | 2022 | 760261 | 0.330 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 1 | 2009 | 69 | 0.320 |
Why?
|
Exanthema | 1 | 2013 | 504 | 0.320 |
Why?
|
Medical Errors | 2 | 2014 | 1255 | 0.320 |
Why?
|
Carbon Monoxide | 1 | 2011 | 541 | 0.310 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 1919 | 0.300 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2014 | 3967 | 0.300 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2012 | 450 | 0.300 |
Why?
|
Crohn Disease | 1 | 2020 | 2275 | 0.290 |
Why?
|
Status Epilepticus | 1 | 2013 | 456 | 0.290 |
Why?
|
Adolescent | 21 | 2022 | 87747 | 0.290 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 488 | 0.290 |
Why?
|
Eosinophilia | 1 | 2012 | 560 | 0.290 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4168 | 0.290 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 934 | 0.290 |
Why?
|
Cerebrovascular Disorders | 1 | 2014 | 1500 | 0.290 |
Why?
|
Antioxidants | 1 | 2015 | 1668 | 0.290 |
Why?
|
Hyperglycemia | 2 | 2017 | 1380 | 0.280 |
Why?
|
Oligopeptides | 1 | 2012 | 1188 | 0.280 |
Why?
|
Workflow | 3 | 2022 | 851 | 0.270 |
Why?
|
Drugs, Generic | 1 | 2012 | 448 | 0.270 |
Why?
|
Blood Glucose | 7 | 2022 | 6375 | 0.270 |
Why?
|
Dietary Supplements | 2 | 2017 | 3389 | 0.260 |
Why?
|
Overweight | 1 | 2017 | 2421 | 0.260 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 5884 | 0.260 |
Why?
|
Diet Records | 2 | 2019 | 427 | 0.260 |
Why?
|
Infant, Newborn | 10 | 2022 | 26168 | 0.250 |
Why?
|
Celiac Disease | 1 | 2013 | 822 | 0.250 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2020 | 2421 | 0.250 |
Why?
|
Male | 37 | 2024 | 359413 | 0.250 |
Why?
|
Influenza, Human | 2 | 2009 | 1532 | 0.250 |
Why?
|
Mutation, Missense | 1 | 2014 | 2563 | 0.240 |
Why?
|
Ambulatory Care | 2 | 2017 | 2783 | 0.240 |
Why?
|
Diabetes Complications | 1 | 2011 | 1342 | 0.240 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3870 | 0.230 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2012 | 1894 | 0.220 |
Why?
|
Immunocompromised Host | 2 | 2013 | 857 | 0.220 |
Why?
|
Immunization Schedule | 2 | 2015 | 225 | 0.220 |
Why?
|
Nutritional Requirements | 2 | 2015 | 275 | 0.220 |
Why?
|
Dietary Fiber | 2 | 2019 | 760 | 0.220 |
Why?
|
Female | 30 | 2022 | 391011 | 0.210 |
Why?
|
Exercise | 2 | 2018 | 5783 | 0.210 |
Why?
|
Sulfonamides | 1 | 2012 | 1973 | 0.210 |
Why?
|
Influenza Vaccines | 1 | 2009 | 770 | 0.200 |
Why?
|
Models, Biological | 1 | 2018 | 9468 | 0.190 |
Why?
|
Computer Simulation | 1 | 2015 | 6210 | 0.190 |
Why?
|
Channelopathies | 1 | 2021 | 30 | 0.190 |
Why?
|
Ribonuclease H | 1 | 2021 | 50 | 0.190 |
Why?
|
Health Promotion | 1 | 2013 | 2208 | 0.190 |
Why?
|
Down Syndrome | 1 | 2009 | 891 | 0.190 |
Why?
|
Anti-Retroviral Agents | 1 | 2011 | 1780 | 0.190 |
Why?
|
Peritoneal Dialysis | 1 | 2022 | 157 | 0.180 |
Why?
|
Aging | 1 | 2019 | 8641 | 0.180 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2020 | 32 | 0.180 |
Why?
|
Skin Diseases, Infectious | 1 | 2020 | 76 | 0.180 |
Why?
|
Pyridines | 1 | 2012 | 2877 | 0.180 |
Why?
|
Fermentation | 1 | 2020 | 146 | 0.180 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7468 | 0.180 |
Why?
|
Anti-Bacterial Agents | 2 | 2017 | 7400 | 0.180 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2021 | 75 | 0.170 |
Why?
|
Skin | 1 | 2013 | 4468 | 0.170 |
Why?
|
Patient Acceptance of Health Care | 1 | 2014 | 3159 | 0.170 |
Why?
|
Influenza A virus | 1 | 2003 | 457 | 0.160 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2024 | 736 | 0.160 |
Why?
|
Nervous System Malformations | 1 | 2021 | 244 | 0.160 |
Why?
|
Antigens, Bacterial | 2 | 2015 | 1155 | 0.160 |
Why?
|
RNA, Viral | 2 | 2020 | 2837 | 0.160 |
Why?
|
Meconium | 1 | 2018 | 47 | 0.160 |
Why?
|
Sodium-Glucose Transport Proteins | 1 | 2018 | 13 | 0.160 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2020 | 514 | 0.160 |
Why?
|
Double-Blind Method | 4 | 2020 | 12412 | 0.160 |
Why?
|
Vaccination | 3 | 2015 | 3360 | 0.150 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2018 | 86 | 0.150 |
Why?
|
Host-Parasite Interactions | 1 | 2020 | 301 | 0.150 |
Why?
|
Weight Loss | 2 | 2021 | 2683 | 0.150 |
Why?
|
Calorimetry, Indirect | 1 | 2018 | 174 | 0.150 |
Why?
|
Phosphates | 1 | 2021 | 771 | 0.150 |
Why?
|
Diet | 1 | 2015 | 8008 | 0.150 |
Why?
|
Endothelium | 1 | 2020 | 764 | 0.140 |
Why?
|
Acute Disease | 4 | 2022 | 7268 | 0.140 |
Why?
|
HIV Infections | 3 | 2015 | 17159 | 0.140 |
Why?
|
Hematopoietic Stem Cells | 2 | 2021 | 3390 | 0.140 |
Why?
|
Milk Hypersensitivity | 1 | 2018 | 78 | 0.140 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1737 | 0.140 |
Why?
|
Hypoglycemia | 2 | 2015 | 888 | 0.140 |
Why?
|
Cohort Studies | 7 | 2022 | 41317 | 0.140 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 1006 | 0.140 |
Why?
|
Systems Integration | 1 | 2018 | 426 | 0.140 |
Why?
|
Anti-HIV Agents | 1 | 2012 | 4492 | 0.130 |
Why?
|
Anthropometry | 2 | 2020 | 1348 | 0.130 |
Why?
|
Area Under Curve | 2 | 2011 | 1635 | 0.130 |
Why?
|
Age Factors | 3 | 2020 | 18415 | 0.130 |
Why?
|
Risk Factors | 7 | 2020 | 74269 | 0.130 |
Why?
|
Treatment Outcome | 8 | 2021 | 64947 | 0.130 |
Why?
|
Risk | 3 | 2020 | 9629 | 0.130 |
Why?
|
Puberty, Precocious | 1 | 2016 | 163 | 0.120 |
Why?
|
Furosemide | 1 | 2015 | 170 | 0.120 |
Why?
|
Young Adult | 9 | 2020 | 58673 | 0.120 |
Why?
|
Cucurbita | 1 | 2014 | 6 | 0.120 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2015 | 146 | 0.120 |
Why?
|
Remission Induction | 1 | 2020 | 2394 | 0.120 |
Why?
|
Serotyping | 1 | 2015 | 324 | 0.120 |
Why?
|
Biological Evolution | 1 | 2020 | 1074 | 0.120 |
Why?
|
Video Recording | 1 | 2019 | 957 | 0.120 |
Why?
|
Drug Monitoring | 1 | 2020 | 966 | 0.120 |
Why?
|
Feces | 1 | 2020 | 1466 | 0.110 |
Why?
|
Hyperemia | 1 | 2015 | 221 | 0.110 |
Why?
|
Jaundice | 1 | 2014 | 97 | 0.110 |
Why?
|
Enalapril | 1 | 2015 | 313 | 0.110 |
Why?
|
Diabetic Nephropathies | 1 | 2021 | 988 | 0.110 |
Why?
|
Incidence | 5 | 2022 | 21378 | 0.110 |
Why?
|
Neisseria meningitidis | 1 | 2014 | 107 | 0.110 |
Why?
|
Triage | 1 | 2020 | 982 | 0.110 |
Why?
|
Iron, Dietary | 1 | 2014 | 148 | 0.110 |
Why?
|
Waist Circumference | 1 | 2017 | 922 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2021 | 12281 | 0.110 |
Why?
|
Food Contamination | 1 | 2014 | 191 | 0.110 |
Why?
|
Liability, Legal | 1 | 2014 | 210 | 0.110 |
Why?
|
Acyclovir | 1 | 2013 | 269 | 0.110 |
Why?
|
Drug Hypersensitivity | 1 | 2022 | 912 | 0.110 |
Why?
|
Iron | 1 | 2021 | 1786 | 0.110 |
Why?
|
Bacterial Capsules | 1 | 2014 | 242 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2021 | 1504 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 936 | 0.100 |
Why?
|
Phenobarbital | 1 | 2013 | 190 | 0.100 |
Why?
|
Diuretics | 1 | 2015 | 612 | 0.100 |
Why?
|
Bacteria | 2 | 2020 | 2196 | 0.100 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6499 | 0.100 |
Why?
|
Adult | 12 | 2022 | 219847 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2018 | 1995 | 0.100 |
Why?
|
Insulin-Secreting Cells | 1 | 2019 | 907 | 0.100 |
Why?
|
Spain | 1 | 2013 | 487 | 0.100 |
Why?
|
Virus Activation | 1 | 2013 | 319 | 0.100 |
Why?
|
National Practitioner Data Bank | 1 | 2011 | 12 | 0.100 |
Why?
|
Medical Records, Problem-Oriented | 1 | 2011 | 35 | 0.100 |
Why?
|
Hemoglobins | 1 | 2017 | 1521 | 0.100 |
Why?
|
Renal Dialysis | 1 | 2021 | 1802 | 0.100 |
Why?
|
Furans | 1 | 2012 | 199 | 0.090 |
Why?
|
Risk Reduction Behavior | 2 | 2015 | 1109 | 0.090 |
Why?
|
Nitric Oxide | 1 | 2020 | 2141 | 0.090 |
Why?
|
Pilot Projects | 2 | 2015 | 8553 | 0.090 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 1067 | 0.090 |
Why?
|
Europe | 1 | 2017 | 3433 | 0.090 |
Why?
|
Equipment Failure | 1 | 2013 | 577 | 0.090 |
Why?
|
Supine Position | 1 | 2011 | 205 | 0.090 |
Why?
|
Sodium, Dietary | 1 | 2014 | 425 | 0.090 |
Why?
|
General Practitioners | 1 | 2012 | 102 | 0.090 |
Why?
|
Infusion Pumps, Implantable | 1 | 2011 | 157 | 0.090 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39254 | 0.090 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 25928 | 0.090 |
Why?
|
Food Hypersensitivity | 1 | 2018 | 692 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1589 | 0.090 |
Why?
|
Primary Prevention | 1 | 2017 | 1207 | 0.090 |
Why?
|
Vaccines, Virosome | 1 | 2009 | 5 | 0.090 |
Why?
|
Neurologic Examination | 1 | 2013 | 916 | 0.090 |
Why?
|
Communicable Diseases | 1 | 2018 | 879 | 0.090 |
Why?
|
Diabetic Ketoacidosis | 1 | 2013 | 257 | 0.090 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2011 | 277 | 0.090 |
Why?
|
Diffusion | 1 | 2011 | 814 | 0.090 |
Why?
|
Splenectomy | 1 | 2011 | 391 | 0.090 |
Why?
|
Physicians, Family | 1 | 2012 | 349 | 0.080 |
Why?
|
Mutation | 4 | 2021 | 29950 | 0.080 |
Why?
|
Homozygote | 1 | 2014 | 1786 | 0.080 |
Why?
|
Blood-Borne Pathogens | 1 | 2009 | 52 | 0.080 |
Why?
|
Dietary Carbohydrates | 1 | 2014 | 893 | 0.080 |
Why?
|
Insulin, Long-Acting | 1 | 2009 | 58 | 0.080 |
Why?
|
Off-Label Use | 1 | 2011 | 184 | 0.080 |
Why?
|
Streptococcus pneumoniae | 1 | 2015 | 732 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4554 | 0.080 |
Why?
|
Outpatients | 2 | 2022 | 1606 | 0.080 |
Why?
|
Baths | 1 | 2009 | 53 | 0.080 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2009 | 83 | 0.080 |
Why?
|
Phenotype | 3 | 2021 | 16543 | 0.080 |
Why?
|
Dietary Proteins | 1 | 2014 | 949 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 2015 | 1558 | 0.080 |
Why?
|
Prednisone | 1 | 2013 | 1566 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 1521 | 0.080 |
Why?
|
Adaptive Immunity | 1 | 2013 | 724 | 0.080 |
Why?
|
Vancomycin Resistance | 1 | 2009 | 126 | 0.080 |
Why?
|
Fluorescein Angiography | 1 | 2013 | 1045 | 0.080 |
Why?
|
Gastroesophageal Reflux | 1 | 2015 | 816 | 0.080 |
Why?
|
Hashimoto Disease | 1 | 2009 | 105 | 0.080 |
Why?
|
Reminder Systems | 1 | 2011 | 387 | 0.080 |
Why?
|
Animals | 11 | 2024 | 167940 | 0.080 |
Why?
|
Glucose | 1 | 2020 | 4361 | 0.080 |
Why?
|
Enterococcus | 1 | 2009 | 160 | 0.080 |
Why?
|
Breast Feeding | 1 | 2016 | 1356 | 0.080 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22025 | 0.070 |
Why?
|
Body Height | 1 | 2014 | 1570 | 0.070 |
Why?
|
Chlorhexidine | 1 | 2009 | 160 | 0.070 |
Why?
|
Cytokines | 2 | 2020 | 7345 | 0.070 |
Why?
|
Health | 1 | 2011 | 395 | 0.070 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2021 | 366 | 0.070 |
Why?
|
Risk Management | 1 | 2011 | 558 | 0.070 |
Why?
|
Canada | 1 | 2013 | 2128 | 0.070 |
Why?
|
Body Mass Index | 2 | 2017 | 12901 | 0.070 |
Why?
|
Endothelium, Vascular | 2 | 2020 | 4437 | 0.070 |
Why?
|
Methicillin Resistance | 1 | 2008 | 199 | 0.070 |
Why?
|
Pregnancy | 2 | 2021 | 29725 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2013 | 1548 | 0.070 |
Why?
|
Anti-Infective Agents, Local | 1 | 2009 | 247 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2015 | 1811 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5644 | 0.070 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2009 | 343 | 0.070 |
Why?
|
Dietary Fats | 1 | 2014 | 1992 | 0.070 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2569 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2557 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1500 | 0.070 |
Why?
|
Salvage Therapy | 1 | 2012 | 1266 | 0.060 |
Why?
|
Drug Resistance, Viral | 1 | 2011 | 859 | 0.060 |
Why?
|
Immune System | 1 | 2011 | 795 | 0.060 |
Why?
|
Primary Health Care | 2 | 2021 | 4649 | 0.060 |
Why?
|
Documentation | 3 | 2022 | 892 | 0.060 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 448 | 0.060 |
Why?
|
Epilepsy | 1 | 2020 | 3267 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2931 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2012 | 2434 | 0.060 |
Why?
|
Proteomics | 1 | 2018 | 3810 | 0.060 |
Why?
|
Drug Industry | 1 | 2011 | 789 | 0.060 |
Why?
|
Visual Acuity | 1 | 2013 | 2635 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2013 | 2143 | 0.060 |
Why?
|
Suicide | 1 | 2015 | 1599 | 0.060 |
Why?
|
Oxidative Stress | 1 | 2015 | 3107 | 0.060 |
Why?
|
Obesity | 3 | 2021 | 12915 | 0.060 |
Why?
|
Body Weight | 1 | 2014 | 4613 | 0.060 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 1935 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2013 | 1881 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8551 | 0.050 |
Why?
|
Viral Load | 1 | 2012 | 3323 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1600 | 0.050 |
Why?
|
Pharmaceutical Preparations | 1 | 2011 | 1093 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15827 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2009 | 695 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6226 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5507 | 0.050 |
Why?
|
Virus Shedding | 1 | 2003 | 111 | 0.050 |
Why?
|
Staphylococcal Infections | 2 | 2009 | 1405 | 0.050 |
Why?
|
Data Collection | 1 | 2012 | 3317 | 0.050 |
Why?
|
Prospective Studies | 4 | 2022 | 54263 | 0.050 |
Why?
|
Energy Metabolism | 1 | 2013 | 2869 | 0.050 |
Why?
|
Drug Resistance, Multiple | 1 | 2003 | 254 | 0.050 |
Why?
|
Mass Screening | 1 | 2017 | 5422 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2015 | 14482 | 0.050 |
Why?
|
Inpatients | 2 | 2011 | 2578 | 0.050 |
Why?
|
Fructosamine | 1 | 2021 | 14 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2013 | 3046 | 0.050 |
Why?
|
Boston | 1 | 2014 | 9282 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8487 | 0.050 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2021 | 66 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3696 | 0.050 |
Why?
|
Lipids | 1 | 2012 | 3336 | 0.050 |
Why?
|
Immunotherapy | 1 | 2017 | 4637 | 0.050 |
Why?
|
Antiviral Agents | 1 | 2013 | 3061 | 0.050 |
Why?
|
Software | 1 | 2015 | 4420 | 0.050 |
Why?
|
Ultrasonography | 1 | 2014 | 5960 | 0.050 |
Why?
|
Hotlines | 1 | 2020 | 55 | 0.050 |
Why?
|
Oropharynx | 1 | 2020 | 132 | 0.040 |
Why?
|
Health Personnel | 1 | 2014 | 3310 | 0.040 |
Why?
|
Autoimmunity | 2 | 2018 | 1370 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20048 | 0.040 |
Why?
|
Glucose Transporter Type 1 | 1 | 2020 | 186 | 0.040 |
Why?
|
Parents | 1 | 2014 | 3547 | 0.040 |
Why?
|
Staphylococcus aureus | 1 | 2008 | 1462 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 12959 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18134 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2020 | 22041 | 0.040 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2020 | 96 | 0.040 |
Why?
|
RNA, Ribosomal, 23S | 1 | 2018 | 54 | 0.040 |
Why?
|
Organizational Case Studies | 1 | 2019 | 301 | 0.040 |
Why?
|
Feedback | 1 | 2022 | 791 | 0.040 |
Why?
|
Quality of Life | 2 | 2022 | 13300 | 0.040 |
Why?
|
New England | 1 | 2021 | 1045 | 0.040 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2020 | 440 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2003 | 1833 | 0.040 |
Why?
|
Bacterial Load | 1 | 2018 | 152 | 0.040 |
Why?
|
Permeability | 1 | 2020 | 719 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2009 | 3145 | 0.040 |
Why?
|
Serum Albumin | 1 | 2021 | 674 | 0.040 |
Why?
|
Milk Proteins | 1 | 2018 | 163 | 0.040 |
Why?
|
Sepsis | 1 | 2011 | 2594 | 0.040 |
Why?
|
United States | 2 | 2017 | 72363 | 0.030 |
Why?
|
Saliva | 1 | 2020 | 816 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2011 | 5324 | 0.030 |
Why?
|
Signal Transduction | 1 | 2019 | 23363 | 0.030 |
Why?
|
Cognition | 1 | 2013 | 6948 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2009 | 3737 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2004 | 1529 | 0.030 |
Why?
|
Sleep | 1 | 2011 | 4746 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3526 | 0.030 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2020 | 853 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8058 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15740 | 0.030 |
Why?
|
Medical Order Entry Systems | 1 | 2019 | 522 | 0.030 |
Why?
|
Child Day Care Centers | 1 | 2015 | 122 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2020 | 3604 | 0.030 |
Why?
|
Population Surveillance | 1 | 2004 | 2609 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1837 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12968 | 0.030 |
Why?
|
Time Factors | 2 | 2019 | 40133 | 0.030 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2003 | 1539 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2022 | 80301 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1455 | 0.030 |
Why?
|
Graft Survival | 1 | 2024 | 3793 | 0.030 |
Why?
|
Mice | 4 | 2024 | 81216 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3302 | 0.030 |
Why?
|
Human papillomavirus 16 | 1 | 2015 | 266 | 0.030 |
Why?
|
Lung | 1 | 2011 | 9989 | 0.030 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2015 | 491 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17766 | 0.030 |
Why?
|
Cattle | 1 | 2018 | 3847 | 0.020 |
Why?
|
Metformin | 1 | 2019 | 912 | 0.020 |
Why?
|
Middle Aged | 5 | 2022 | 220175 | 0.020 |
Why?
|
Heart Failure | 1 | 2015 | 11835 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8621 | 0.020 |
Why?
|
Drug Interactions | 1 | 2015 | 1426 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2013 | 1628 | 0.020 |
Why?
|
Aged | 4 | 2022 | 168995 | 0.020 |
Why?
|
Immunization | 1 | 2015 | 1228 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2024 | 3217 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4127 | 0.020 |
Why?
|
Allergens | 1 | 2018 | 1399 | 0.020 |
Why?
|
Inflammation | 2 | 2020 | 10757 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 24086 | 0.020 |
Why?
|
Reference Standards | 1 | 2013 | 1004 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3207 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2017 | 895 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2021 | 2469 | 0.020 |
Why?
|
Hypertension | 2 | 2020 | 8595 | 0.020 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2008 | 144 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4357 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2018 | 5873 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10530 | 0.020 |
Why?
|
Patient Care | 1 | 2013 | 624 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8805 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5498 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2020 | 4012 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10183 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 7592 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2020 | 3960 | 0.020 |
Why?
|
Brain | 1 | 2013 | 26912 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 36247 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10552 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15626 | 0.020 |
Why?
|
Life Style | 1 | 2017 | 3888 | 0.020 |
Why?
|
Stem Cells | 1 | 2017 | 3525 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 18968 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2020 | 3524 | 0.010 |
Why?
|
Smoking | 1 | 2020 | 9070 | 0.010 |
Why?
|
Phylogeny | 1 | 2008 | 2775 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29636 | 0.010 |
Why?
|
Cesarean Section | 1 | 2004 | 1386 | 0.010 |
Why?
|
Cross Infection | 1 | 2004 | 1434 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2004 | 2273 | 0.010 |
Why?
|
Mammaplasty | 1 | 2004 | 1239 | 0.010 |
Why?
|
Patient Discharge | 1 | 2004 | 3475 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2008 | 58947 | 0.000 |
Why?
|